Citius Pharmaceuticals, Inc. - COM NEW (CTXR)

Historical Portfolio Holders from Q3 2017 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q3 2024
23.6M
Holdings value Q3 2024
$11.8M
Value change Q3 2024
-$3.64M
Grand Portfolio weight change Q3 2024
0%
Number of holders
55
Number of buys Q3 2024
0
Number of sells Q3 2024
0
Average buys Q3 2024 %
0
Average sells Q3 2024 %
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 23.6M $11.8M -$3.64M $0.50 56
2024 Q2 30.6M $17.9M +$1.84M $0.58 67
2024 Q1 27M $24.2M +$162K $0.90 72
2023 Q4 26.8M $20.3M +$1.57M $0.76 73
2023 Q3 24.9M $17.1M -$571K $0.68 73
2023 Q2 25.3M $30.4M +$13M $1.20 73
2023 Q1 14.5M $16.9M +$348K $1.17 55
2022 Q4 14.2M $11.3M +$185K $0.79 50
2022 Q3 13.7M $16.6M -$1.6M $1.21 48
2022 Q2 15.2M $13.9M -$10M $0.92 50
2022 Q1 24.1M $43.2M -$567K $1.79 67
2021 Q4 24.4M $37.6M -$2.19M $1.54 70
2021 Q3 25.1M $51M -$897K $2.03 69
2021 Q2 25.1M $87.5M +$51M $3.48 70
2021 Q1 10.8M $19.3M +$16.4M $1.78 37
2020 Q4 1.81M $1.85M +$727K $1.02 22
2020 Q3 1.05M $1.09M +$248K $1.04 16
2020 Q2 969K $1.09M -$543K $1.12 13
2020 Q1 2.14M $1.3M +$856K $0.59 9
2019 Q4 684K $698K -$703K $1.02 8
2019 Q3 1.46M $1.11M +$618K $0.77 9
2019 Q2 624K $612K +$245K $1.00 9
2019 Q1 351K $498K -$522K $1.42 10
2018 Q4 926K $962K +$671K $1.04 8
2018 Q3 253K $434K -$473K $1.71 9
2018 Q2 525K $1.21M -$401K $2.30 6
2018 Q1 699K $2.17M +$1.44M $3.08 6
2017 Q4 238K $926K +$808K $3.89 7
2017 Q3 35.3K $111K +$111K $3.16 4